ASH 2013 - Andrew Artz on Allogeneic Transplant for High Risk Myelodysplastic Syndromes and AML
2 Views
administrator
07/04/23
From ASH 2013, Andrew Artz, M.D., M.S., discusses his educational session on Allogeneic Transplant for High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia: Are We Improving Outcomes?
-
Category
Show more
Facebook Comments
No comments found